Page last updated: 2024-12-08
roxifiban acetate
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
roxifiban acetate: structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 164518 |
CHEMBL ID | 2107050 |
SCHEMBL ID | 919675 |
MeSH ID | M0576952 |
Synonyms (27)
Synonym |
---|
dmp-754 |
xu-070 |
dmp-755 |
lumaxis |
roxifiban acetate |
sc-887 |
D05772 |
roxifiban acetate (usan) |
176022-59-6 |
dmp 754 |
(2s)-3-(2-((5s)-3-(p-amidinophenyl)-2-isoxazolin-5-yl)acetamido)-2-(carboxyamino)propionic acid, 2-butyl methyl ester, monoacetate |
(2s)-3-(2-((5r)-3-(p-amidinophenyl)-2-isoxazolin-5-yl)acetamido)-2-(carboxyamino)propionic acid, 2-butyl methyl ester, monoacetate |
l-alanine, 3-(((3-(4-(aminoiminomethyl)phenyl)-4,5-dihydro-5-isoxazolyl)acetyl)amino)-n-(butoxycarbonyl)-, methyl ester, (r)-, monoacetate |
roxifiban acetate [usan] |
unii-0u90eod13m |
0u90eod13m , |
l-alanine, 3-((((5r)-3-(4-(aminoiminomethyl)phenyl)-4,5-dihydro-5-isoxazolyl)acetyl)amino)-n-(butoxycarbonyl)-, methyl ester, monoacetate |
methyl n(3)-(2-(3-(4-formamidinophenyl)isoxazolin-5-yl)acetyl)-n(2)-(1-butyloxycarbonyl)-2,3-diaminopropionate |
CHEMBL2107050 |
roxifiban acetate [who-dd] |
WDEMHBVIYZGQCD-KALLACGZSA-N |
SCHEMBL919675 |
DTXSID90170069 |
methyl (s)-2-((butoxycarbonyl)amino)-3-(2-((r)-3-(4-carbamimidoylphenyl)-4,5-dihydroisoxazol-5-yl)acetamido)propanoate acetate |
Q27237261 |
acetic acid;methyl (2s)-2-(butoxycarbonylamino)-3-[[2-[(5r)-3-(4-carbamimidoylphenyl)-4,5-dihydro-1,2-oxazol-5-yl]acetyl]amino]propanoate |
AKOS040746302 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (8)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 6 (75.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.02
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.02) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 8 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |